Volume 72, Issue 8, Pages (October 2007)

Slides:



Advertisements
Similar presentations
An alcoholic patient with recurrent renal failure and proteinuria T. Kumagai, Y. Hori, G. Seki, Toshiro Fujita Kidney International Volume 70, Issue 8,
Advertisements

Epoetin use and Kidney Disease Outcomes Quality Initiative hemoglobin targets in patients returning to dialysis with failed renal transplants  C.A. Solid,
NOD-like and Toll-like receptors or inflammasomes contribute to kidney disease in a canonical and a non-canonical manner  Hans-Joachim Anders, Maciej.
Volume 71, Issue 11, Pages (June 2007)
Toll-like receptor activation: from renal inflammation to fibrosis
FGF23–parathyroid interaction: implications in chronic kidney disease
Innate immunity as a driving force in renal disease
EGFR signaling in renal fibrosis
M. Fukagawa, S. Nakanishi, J.J. Kazama  Kidney International 
Burden of chronic kidney disease: North Africa
Volume 71, Issue 8, Pages (April 2007)
Volume 70, Pages S21-S25 (December 2006)
John G. Monroe, Mary E. Keir  Immunity 
Volume 86, Issue 4, Pages (October 2014)
Volume 70, Issue 7, Pages (October 2006)
Comorbidity and confounding in end-stage renal disease
Experimental Hematology
Gregory B. Vanden Heuvel  Kidney International 
Targeting Smads to Restore Transforming Growth Factor-β Signaling and Regulatory T- Cell Function in Inflammatory Bowel Disease  Deanna D. Nguyen, Scott.
Volume 70, Issue 11, Pages (December 2006)
Volume 73, Issue 4, Pages (February 2008)
D. Coyne  Kidney International  Volume 69, Pages S1-S3 (May 2006)
Hans-Joachim Anders, Kirstin Andersen, Bärbel Stecher 
Volume 71, Issue 6, Pages (March 2007)
Saulo Klahr, Jeremiah J. Morrissey  Kidney International 
Volume 70, Issue 12, Pages (December 2006)
Karsten Bartels, Almut Grenz, Holger K. Eltzschig  Kidney International 
Volume 70, Issue 7, Pages (October 2006)
Fructose intake as a risk factor for kidney stone disease
Nitric oxide and vascular remodeling: Spotlight on the kidney
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Twist: a new link from hypoxia to fibrosis
Yin and Yang: The Dao of the kidney
Matrix metalloproteinases and matrix receptors in progression and reversal of kidney disease: therapeutic perspectives  Pierre Ronco, Christos Chatziantoniou 
What can be learned using microarrays?
Volume 95, Issue 4, Pages (April 2019)
New paradigms in cell death in human diabetic nephropathy
Volume 71, Issue 11, Pages (June 2007)
Volume 82, Issue 9, Pages (November 2012)
Volume 69, Issue 11, Pages (June 2006)
Paola Romagnani, Hans-Joachim Anders  Kidney International 
Epoetin use and Kidney Disease Outcomes Quality Initiative hemoglobin targets in patients returning to dialysis with failed renal transplants  C.A. Solid,
NODding off in acute kidney injury with progranulin?
Cisplatin nephrotoxicity: Mechanisms and renoprotective strategies
Organ transplantation goes to the movies
Low triiodothyronine and survival in end-stage renal disease
Molecular mechanisms of renal hypertrophy: Role of p27Kip1
Volume 72, Issue 2, Pages (July 2007)
Volume 69, Issue 5, Pages (March 2006)
Volume 80, Issue 10, Pages (November 2011)
Volume 70, Issue 6, Pages (September 2006)
Is it the low-protein diet or simply the salt restriction?
Treatment of the primary hyperoxalurias: A new chapter
Is complement a target for therapy in renal disease?
Volume 70, Issue 3, Pages (August 2006)
Volume 71, Issue 9, Pages (May 2007)
Volume 70, Issue 5, Pages (September 2006)
Volume 75, Issue 7, Pages (April 2009)
Volume 70, Issue 2, Pages (July 2006)
Volume 84, Issue 6, Pages (December 2013)
Volume 75, Issue 6, Pages (March 2009)
T cells and T-cell receptors in acute renal failure
Volume 70, Issue 10, Pages (November 2006)
The International Pediatric Peritonitis Registry: Starting to walk
In chronic kidney disease staging the use of the chronicity criterion affects prognosis and the rate of progression  B.O. Eriksen, O.C. Ingebretsen  Kidney.
Therapy with lamivudine and steroids in a patient with acute hepatitis B and rapidly progressive glomerulonephritis  V. Di Marco, S. De Lisi, M. Li Vecchi,
Tetany during bicarbonate loading test
Renoprotection with vitamin D: Specific for diabetic nephropathy?
Presentation transcript:

Volume 72, Issue 8, Pages 918-925 (October 2007) Leptospirosis renal disease: Understanding the initiation by Toll-like receptors  C.-W. Yang  Kidney International  Volume 72, Issue 8, Pages 918-925 (October 2007) DOI: 10.1038/sj.ki.5002393 Copyright © 2007 International Society of Nephrology Terms and Conditions

Figure 1 Differential induction of early inflammatory genes via TLR2 Pathway by leptospira OMP in renal proximal tubule cells. NF-κB and MAPK pathways can be activated and be inhibited by siRNA and inhibitors for each component and pathway. Kidney International 2007 72, 918-925DOI: (10.1038/sj.ki.5002393) Copyright © 2007 International Society of Nephrology Terms and Conditions

Figure 2 Leptospira induces fibrosis pathway in the tubule cells by activating TGF-β1/Smad pathway but not MAPK. The activation results in increased production of extracellular matrix in the renal tubule cells. These activations may lead to renal fibrosis in leptospirosis patients. Kidney International 2007 72, 918-925DOI: (10.1038/sj.ki.5002393) Copyright © 2007 International Society of Nephrology Terms and Conditions

Figure 3 The possible role of TLRs in initiation of kidney diseases. TLRs may be involved in the initiation of diverse renal diseases in response to exogenous and endogenous stimuli. On one hand, TLRs are the first line of defence for innate immune protection. Conversely, TLRs may act as a ‘danger signal’ by triggering inflammatory responses to stimuli when tailored immune reactions cannot adequately resolve the inflammation. The outcome may thus depend on a balanced or unbalanced immune reaction leading to either resolution or disease progression to renal fibrosis and end-stage renal disease. Kidney International 2007 72, 918-925DOI: (10.1038/sj.ki.5002393) Copyright © 2007 International Society of Nephrology Terms and Conditions